Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 376 AL 390

ALZHEIMER'S DISEASE AND ITS RELATIONSHIP WITH THE MICROBIOTA-GUT-BRAIN AXIS

Faulin TDES, Estadella D.

Arq Gastroenterol. 2023 Jan-Mar;60(1):144-154. doi: 10.1590/S0004-2803.202301000-17.

The relationship between long non-coding RNAs and Wnt/β-catenin signaling pathway in the pathogenesis of Alzheimer's disease

Ghasemi A, Qaffaripour Z, Tourani M, Saleki K, Rahmani-Kukia N, Khatami SH, Taheri-Anganeh M.

Exp Neurol. 2023 Aug;366:114434. doi: 10.1016/j.expneurol.2023.114434. Epub 2023 May 16.

Clinical relevance of animal models in aging-related dementia research

Padmanabhan P, Götz J.

Nat Aging. 2023 May;3(5):481-493. doi: 10.1038/s43587-023-00402-4. Epub 2023 May 18.

Treatment for Alzheimer's disease: time to get ready

The Lancet Neurology.

Lancet Neurol. 2023 Jun;22(6):455. doi: 10.1016/S1474-4422(23)00167-9.

Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review

Zhao D, Yang K, Guo H, Zeng J, Wang S, Xu H, Ge A, Zeng L, Chen S, Ge J.

Biomed Pharmacother. 2023 Aug;164:114312. doi: 10.1016/j.biopha.2023.114312. Epub 2023 May 19.

Neurogenomics of Alzheimer's disease (AD): An Asian population review

Besin V, Humardani FM, Mulyanata LT.

Clin Chim Acta. 2023 Jun 1;546:117389. doi: 10.1016/j.cca.2023.117389. Epub 2023 May 19.

The Time for Combination Therapy Research in Alzheimer's Disease is Now

Dinnerstein E.

J Alzheimers Dis. 2023;93(3):925-926. doi: 10.3233/JAD-230254.

Striking a NRF2: The Rusty and Rancid Vulnerabilities Toward Ferroptosis in Alzheimer's Disease

Lane DJR, Alves F, Ayton SJ, Bush AI.

Antioxid Redox Signal. 2023 Jul;39(1-3):141-161. doi: 10.1089/ars.2023.0318.

Neuronal Transplantation for Alzheimer's Disease and Prospects for Generating Exogenic Neurons as a Source of Cells for Implantation

Strell P, Johnson ST, Carchi C, Low WC.

Cell Transplant. 2023 Jan-Dec;32:9636897231164712. doi: 10.1177/09636897231164712.

Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs

Thakral S, Yadav A, Singh V, Kumar M, Kumar P, Narang R, Sudhakar K, Verma A, Khalilullah H, Jaremko M, Emwas AH.

Ageing Res Rev. 2023 Jul;88:101960. doi: 10.1016/j.arr.2023.101960. Epub 2023 May 22.

ApoE4-mediated blood-brain barrier damage in Alzheimer's disease: Progress and prospects

Zhou X, Shi Q, Zhang X, Gu L, Li J, Quan S, Zhao X, Li Q.

Brain Res Bull. 2023 Jul;199:110670. doi: 10.1016/j.brainresbull.2023.110670. Epub 2023 May 22.

Nondeclarative associative learning in Alzheimer's disease: An overview of eyeblink, fear, and other emotion-based conditioning

Maturana W, Lobo I, Landeira-Fernandez J, Mograbi DC.

Physiol Behav. 2023 Sep 1;268:114250. doi: 10.1016/j.physbeh.2023.114250. Epub 2023 May 22.

Alzheimer Disease and Epilepsy: A Mendelian Randomization Study

Fang Y, Si X, Wang J, Wang Z, Chen Y, Liu Y, Yan Y, Tian J, Zhang B, Pu J.

Neurology. 2023 Jul 25;101(4):e399-e409. doi: 10.1212/WNL.0000000000207423. Epub 2023 May 24.

Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review

Dickson SP, Hennessey S, Nicodemus Johnson J, Knowlton N, Hendrix SB.

Alzheimers Res Ther. 2023 May 24;15(1):98. doi: 10.1186/s13195-023-01238-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias